Investigation into the correlation between the structure of hydroxypyridinones and blood-brain barrier permeability

Biochemical Pharmacology

Volumn 57, Issue 11, 1999, Pages 1305-1310

  Habgood, Mark D ^a   Liu, Zu Dong ^a   Dehkordi, Lotfollah S ^a   Khodr, Hicham H ^a   Abbott, Joan ^a   Hider, Robert C ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Blood brain barrier; Hydroxypyridinone; Iron chelators

Indexed keywords

IRON CHELATING AGENT; PYRIDONE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; BRAIN PERFUSION; CHEMICAL STRUCTURE; DRUG STRUCTURE; HUMAN TISSUE; IRON OVERLOAD; MALE; NONHUMAN; PERMEABILITY BARRIER; PRIORITY JOURNAL; RAT;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; IRON CHELATING AGENTS; MALE; PYRIDINES; RATS; RATS, WISTAR; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0033152287     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(99)00031-3     Document Type: Article

References (22)

1. Weatherall D.J., Clegg J.B. The Thalassaemia Syndromes. 3rd ed. 1981;Blackwell Scientific Press, Oxford.
2. Tilbrook G.S., Hider R.C. Iron chelators for clinical use. Sigel A., Sigel H., Metal ions in biological systems Iron transport and storage in microorganisms, plants, and animals . Vol. 35:1998;691-730 Marcel Dekker, New York.
3. Levin V.A. Relationship of octanol/water partition coefficient and molecular weight to rat brain capillary permeability. J Med Chem. 23:1980;682-684.
4. Pardridge V.M. Drug delivery to the brain. J Cerebral Blood Flow Metab. 17:1998;713-731.
5. Oldendorf W.H. Lipid solubility and drug penetration of the blood-brain barrier. Proceedings Soc Expt Bio Med. 147:1974;813-816.
6. Mayer S., Marckel R.P., Brodie B.B. Kinetics of penetration of drugs and other foreign compounds in cerebrospinal fluid and brain. J Pharmacol Exp Ther. 127:1959;205-211.
7. Brodie B.B., Kurz H., Schanker L.S. The importance of dissociation constant and lipid solubility in influencing the passage of drug into the cerebrospinal fluid. J Pharmacol Exp Ther. 130:1960;20-25.
8. Rapoport S.I., Ohno K., Pettigrew K.D. Drug entry into the brain. Brain Res. 172:1979;354-359.
9. Goldstein G.W., Betz A.L. The blood-brain barrier. Sci Am. 255:1986;74-83.
10. Greig N.H., Sancrant T.T., Shetty H.U., Momma S., Smith Q.R., Rapoport S.I. Brain uptake and anticancer activities of vincristine and vinblastine are restricted by their low cerebrovascular permeability and binding to plasma constituents in rat. Cancer Chemother Pharmacol. 26:1990;263-268.
11. 2 receptor histamine antogonists. J Med Chem. 31:1988;656-671.
12. Dobbin P.S., Hider R.C., Hall A.D., Taylor P.D., Sarpong P., Porter J.B., Xiao G., van der Helm D. Synthesis, physicochemical properties, and biological evaluation of N-substituted 2-alkyl-3-hydroxy-4(1H)-pyridinones Orally active iron chelators with clinical potential . J Med Chem. 36:1993;2448-2458.
13. Rai B.L., Dekhordi L.S., Khodr H., Jin Y., Liu Z., Hider R.C. Synthesis, physicochemical properties and evaluation of N-substituted-2-alkyl-3-hydroxy-4(1H)-pyridinones. J Med Chem. 41:1998;3347-3359.
14. Hall A. TOPCAT Program for Determination of Distribution Coefficients. 1990;Department of Pharmacy, King's College, London.
15. Khodr H. KDHK94 Program (A Modified Version of TOPCAT Program) for Determination of Distribution Coefficients. 1994;Department of Pharmacy, King's College, London.
16. Takasato Y., Rapoport S.I., Smith Q.R. An in situ brain perfusion technique to study cerebrovascular transport in the rat. Am J Physiol. 247:1984;H484-H493.
17. Ohno K., Pettigrew K.D., Rapoport S.I. Lower limits of cerebrovascular permeability to non-electrolytes in the conscious rat. Am J Physiol. 235:1978;H299-H307.
18. Bradbury M.W.B. The Concept of a Blood-Brain Barrier. 1970;Wiley & Sons, Chichester.
19. Stein W.D. The Movement of Molecules across Cell Membrane. 1967;Academic Press, New York.
20. Abraham M.H., Chadha H.S., Whiting G.S., Mitchell R.C. Hydrogen bonding. Part 32: An analysis of water-octanol and water-alkane partitioning and the ΔlogP parameter of Seiler . J Pharm Sci. 83:1994;1085-1100.
21. Abraham M.H., Chadha H.S., Mitchell R.C. The factors that influence the distribution of solutes between blood and brain. J Pharm Sci. 83:1994;1257-1268.
22. Gratton J.A., Abraham M.H., Bradbury M.W., Chadha H.S. Molecular factors influencing drug transfer across the blood-brain barrier. J Pharm Pharmacol. 49:1997;1211-1216.